Dose Regimen Rationale for Panitumumab in Cancer Patients: To Be Based on Body Weight or Not

Por Liao, Michael Z, Berkhout, Marloes, Prenen, Hans, Dutta, Sandeep, Upreti, Vijay V
Publicado no Clin Pharmacol (2020)

Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Response to Letter]

Por Liao, Michael Z, Kast, Johannes, Berkhout, Marloes, Prenen, Hans, Dutta, Sandeep, Upreti, Vijay V
Publicado no Clin Pharmacol (2020)

Mechanisms of MDMA (Ecstasy)-Induced Oxidative Stress, Mitochondrial Dysfunction, and Organ Damage

Por Song, Byoung-Joon, Moon, Kwan-Hoon, Upreti, Vijay V., Eddington, Natalie D., Lee, Insong J.
Publicado em 2010

Drug Interaction Between Ethanol and 3,4-Methylenedioxymethamphetamine (“ecstasy”)

Por Upreti, Vijay V., Eddington, Natalie D., Moon, Kwan-Hoon, Song, Byoung-Joon, Lee, Insong J.
Publicado em 2009

Effect of rifampicin on the pharmacokinetics and pharmacodynamics of saxagliptin, a dipeptidyl peptidase-4 inhibitor, in healthy subjects

Por Upreti, Vijay V, Boulton, David W, Li, Li, Ching, Agatha, Su, Hong, LaCreta, Frank P, Patel, Chirag G
Publicado em 2011

Effect of famotidine on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor

Por Upreti, Vijay V, Song, Yan, Wang, Jessie, Byon, Wonkyung, Boyd, Rebecca A, Pursley, Janice M, LaCreta, Frank, Frost, Charles E
Publicado em 2013

Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects

Por Upreti, Vijay V, Wang, Jessie, Barrett, Yu Chen, Byon, Wonkyung, Boyd, Rebecca A, Pursley, Janice, LaCreta, Frank P, Frost, Charles E
Publicado em 2013

Mechanism of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-mediated mitochondrial dysfunction in rat liver

Por Moon, Kwan-Hoon, Upreti, Vijay V., Yu, Li-Rong, Lee, Insong J., Ye, Xiaoying, Eddington, Natalie D., Veenstra, Timothy D., Song, Byoung-Joon
Publicado em 2008

Increased oxidative-modifications of cytosolic proteins in 3, 4-methylenedioxymethamphetamine (MDMA, Ecstasy)-exposed rat liver

Por Upreti, Vijay V., Moon, Kwan-Hoon, Yu, Li-Rong, Lee, Insong J., Eddington, Natalie D., Ye, Xiaoying, Veenstra, Timothy D., Song, Byoung-Joon
Publicado em 2010

Evaluation of the Transport, In Vitro Metabolism and Pharmacokinetics of Salvinorin A, a Potent Hallucinogen

Por Teksin, Zeynep S., Lee, Insong J., Nemieboka, Noble N., Othman, Ahmed A., Upreti, Vijay V., Hassan, Hazem E., Syed, Shariq S., Prisinzano, Thomas E., Eddington, Natalie D.
Publicado em 2009

Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor–related protein agonist AMG 228 in patients with advanced solid tumors

Por Tran, Ben, Carvajal, Richard D., Marabelle, Aurelien, Patel, Sandip Pravin, LoRusso, Patricia M., Rasmussen, Erik, Juan, Gloria, Upreti, Vijay V., Beers, Courtney, Ngarmchamnanrith, Gataree, Schöffski, Patrick
Publicado no J Immunother Cancer (2018)

VN/14-1 induces ER stress and autophagy in HP-LTLC human breast cancer cells and has excellent oral pharmacokinetic profile in female Sprague Dawley rats

Por Godbole, Abhijit M., Ramalingam, Senthilmurugan, Ramamurthy, Vidya P., Khandelwal, Aakanksha, Bruno, Robert D., Upreti, Vijay V., Gediya, Lalji K., Purushottamachar, Puranik, Mbatia, Hannah W., Addya, Sankar, Ambulos, Nicholas, Njar, Vincent C. O.
Publicado em 2014

Recommendations for the Design of Clinical Drug–Drug Interaction Studies With Itraconazole Using a Mechanistic Physiologically‐Based Pharmacokinetic Model

Por Chen, Yuan, Cabalu, Tamara D., Callegari, Ernesto, Einolf, Heidi, Liu, Lichuan, Parrott, Neil, Peters, Sheila Annie, Schuck, Edgar, Sharma, Pradeep, Tracey, Helen, Upreti, Vijay V., Zheng, Ming, Zhu, Andy Z.X., Hall, Stephen D.
Publicado no CPT Pharmacometrics Syst Pharmacol (2019)